Speakers

Prof. Dr. Karim Nayernia

Prof. Dr. Karim Nayernia

CEO, International Center for Personalized
Medicine, Germany

Title: Personalized Cell Therapy of cardiovascular diseases
Dr. med. Elham Kayvanpour

Dr. med. Elham Kayvanpour

Specialist, Institute of cardiomyopathies,University
Hospital Heidelberg, Germany

Title: Towards Individualized Therapy of Ischemic and  Non-Ischemic Heart Failure Patients
Prof. Dr. Jürgen Hescheler

Prof. Dr. Jürgen Hescheler

 Director, Institute for Neurophysiology,
University of Cologne,Germany

Title: Personalized Medicine Based on Induced Pluripotent Stem Cells
Prof. Dr. Heribert Schunkert

Prof. Dr. Heribert Schunkert

Director, German Heart Centre,
Munich,Germany

Title: Multiplicative Effects of CAD Risk Alleles
Prof. Dr. Uwe Nixdorff

Prof. Dr. Uwe Nixdorff

CEO, European Prevention Center,
Germany

Title: What Is The Privative Potential or Genetic Analysis in Clinical Cardiology?
Prof. Dr. Grant Morahan

Prof. Dr. Grant Morahan

Head of Centre for Diabetes Research,
University of Western Australia

Title: Genetic Risk Signatures Identifying People at Higher Risk of Cancer, Heart Attack and Other Diseases
Prof. Dr. Jeffrey K. Mills

Prof. Dr. Jeffrey K. Mills

CEO, Medler Ferro Woodhouse & Mills, USA

Title: Protecting Personalized Medicine Innovation in Europe and the US: Challenges and Opportunities
Prof. Dr. Kewal K. Jain

Prof. Dr. Kewal K. Jain

CEO, Jain PharmaBiotech, Switzerland

Title: Integration of Biotechnologies for The Development of Personalized Medicine for Cardiovascular Disorders
Dr. med. Majd AlGhatrif

Dr. med. Majd AlGhatrif

Head of Human Cardiovascular Studies (NIA),
Johns Hopkins School of Medicine,USA

Title: Precious Medicine in Ambiguous Diseases Individualizing care in Age-Associated Cardiovascular Conditions
Prof. Dr. Joseph Loscalzo

Prof. Dr. Joseph Loscalzo

Head of the Department of Medicine at Brigham &
Women’s Hospital, Harvard Medical School, USA

Title: Network Medicine: A Path to Precision Cardiovascular Medicine
Dr. Thomas Bauer

Dr. Thomas Bauer

Business Development Director, Germany

Title: Personalized Medicine: Market considerations and aspects from a Start-Up perspective
Dr. David A. Nelles

Dr. David A. Nelles

CEO of Tartan LLC, USA

Title: RNA-targeting Cas9 Corrects Molecular and Physiological Features of Myotonic Dystrophy Type I”
Dr. Leo Kurian

Dr. Leo Kurian

Principal Investigator, Institute for Neurophysiology,
university of Cologne,Germany

Title: Loss of Genomic Integrity Induced by Lysosphingolipid Imbalance Drives Ageing in the Heart
Search